Recent study shows cost savings of $3,672 from a societal perspective and $2,990 from a health care sector perspective<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, Aug. 6, 2024 (HealthDay News) — For individuals with prediabetes, a digital diabetes prevention program (d-DPP) is cost-effective compared with an in-person lifestyle intervention for preventing development of type 2 diabetes (T2D), according to a study published online July 26 in Diabetes, Obesity and Metabolism<\/em>.<\/p>\n Sooyeol Park, from the Tulane University School of Public Health and Tropical Medicine in New Orleans, and colleagues examined the cost-effectiveness of a d-DPP versus a DPP for preventing T2D in individuals with prediabetes. A Markov cohort model was constructed, which simulated a 10-year period starting at 45 years of age.<\/p>\n The researchers found cost savings of $3,672 and $2,990 from a societal perspective and from a health care sector perspective, respectively, as well as a gain of 0.08 quality-adjusted life years resulting from the d-DPP intervention versus the DPP. A significant factor influencing the results was the dropout rate. The d-DPP intervention was preferred in 85.8 percent in the societal perspective and 85.2 percent in the health care sector perspective.<\/p>\n “Based on the current study’s findings, d-DPPs can be an alternative to in-person DPPs. The cost savings of prevented cases of T2D with d-DPPs can improve the sustainability for patients with prediabetes,” the authors write. “Our findings provide economic evidence that the d-DPP provides good value for money in preventing T2D in high-risk patients in the U.S. setting.”<\/p>\n